With Eye on China’s Vaccine Diplomacy, India & US Must Collaborate to Meet Needs of Developing World
News 18External Affairs Minister S. Jaishankar’s visit to the US comes at a time when the second wave of the Wuhan virus is ravaging India, the situation on the border in Ladakh is stalemated, the US policy towards China is hardening. A fall out of shared maritime security concerns opens up the Indian defence market more to the US military equipment, with the collateral advantage of weaning away India progressively from Russian supplies. Our strategy seems to be to persuade the US government and the US companies manufacturing vaccines and the required ingredients to cooperate with India to not only meet our needs but also of the developing countries in general, as India has the capacity to produce vaccines in large quantities and at low cost, which the US does not. What India needs is the US government support to persuade the US companies to ramp up production of ingredients which can be bought commercially by Indian producers. At the same time, India would welcome the US Pharma giants collaborating commercially with Indian companies to produce vaccines in India.